Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Kilitch Drugs (India) Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

70/100
393.50
-6.50 (-1.63%)

As on 29 Oct, 2025 | 03:47

Open Trading A/c
Day Range
379.00
414.90
L H
52 Week Range
299.95
500.00
L H
Volume
121,956
*
i

* BSE Market Depth (29 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
55 388.45 396.90 1
55 388.35 398.00 20
2 388.05 398.90 20
50 386.50 398.95 51
50 386.35 399.00 50
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
70/100
391.10
-10.00 (-2.49%)

As on 29 Oct, 2025 | 04:01

Open Trading A/c
Day Range
380.00
412.30
L H
52 Week Range
265.50
490.00
L H
Volume
5,736
*
i

* BSE Market Depth (29 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
55 388.45 396.90 1
55 388.35 398.00 20
2 388.05 398.90 20
50 386.50 398.95 51
50 386.35 399.00 50
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
NSE
MC Essentials
71% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock at Attractive Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 404.60
          Previous Close 400.00
          Volume 121,956.00
          Value (Lacs) 479.90
            VWAP 398.67
          Beta
          Mkt Cap (Rs. Cr.) 688
          High 414.90
          Low 379.00
          UC Limit 480.00
          LC Limit 320.00
          52 Week High 500.00
          52 Week Low 299.95
          Face Value 10.00
          All Time High 500.00
          All Time Low 17.00
          20D Avg Volume 40,798
          20D Avg Delivery(%) 45.68
          Book Value Per Share 144.30
          Dividend Yield 0.00
          TTM EPS See historical trend 16.02 (+70.14% YoY)
          TTM PE See historical trend 24.56 (Low PE)
          P/B See historical trend 2.73 (Average P/B)
          Sector PE 39.56

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          70/100
          Superior Financial Strength, High Growth Trend Stock at Attractive Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 21.30% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 69.23% to 63.77% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 16 years Kilitch Drugs (India) has given positive returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 30.65% (2018) 15.22% -23.53% (2011) -10.20% 4.10%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 0% BUY
          • 0% SELL
          • 100% HOLD
          100%
          of moneycontrol users recommend holding Kilitch Drugs

          What's your call on Kilitch Drugs today?

          Read 1 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          28 Oct, 2025

          Shreni Shares Pvt

          Qty 117495 Price 405.58 % Traded 0.68
          28 Oct, 2025

          Shreni Shares Pvt

          Qty 32332 Price 401.82 % Traded 0.19

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Kilitch Drugs 393.50 -1.63 687.87 24.56 2.73 13.19 29.23 24 198 0.24
          Sun Pharma 1,715.90 1.71 411,701.89 39.69 5.96 15.13 -9.83 10,980 52,578 0.03
          Divis Labs 6,512.00 1.14 172,873.14 74.96 12.60 14.63 12.00 2,191 9,360 0.00
          Cipla 1,581.10 0.83 127,715.83 23.68 4.50 16.90 5.19 5,291 27,547 0.00
          Torrent Pharma 3,599.30 0.64 121,816.67 60.85 16.23 25.17 8.52 1,911 11,516 0.40
          + See More

          About the Company

          Kilitch Drugs (India) Limited is an India-based company engaged in pharmaceutical business. The Companys services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms. The Company is a manufacturer of antibacterial parenteral formulations. Its products include Carbapenems, Cephalosporins, Aminoglycosides, anti malarials, and other anti-infectives. The Company trades in Eyekare Pharmaceuticals products and is located in Mumbai. On February 28, 2012, the Company discontinued its manufacturing activity at Paonta Sahib. The Company also transferred certain products by entering into a product transfer agreement with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.
          {"success":1,"data":{"address":{"address1":"C-301\/2, M.I.D.C.,","address2":",","city":"New Mumbai","state":"Maharashtra","pincode":"400705","telephone1":"022-27670322","telephone2":"022-27680913","fax1":"022-27680912","fax2":"","email":"info@kilitch.com","web":"http:\/\/www.kilitch.com"},"management":[{"name":"Mukund P Mehta","designation":"Managing Director"},{"name":"Bhavin Mukund Mehta","designation":"Whole Time Director"},{"name":"Mira B Mehta","designation":"Whole Time Director"},{"name":"Hemang J Engineer","designation":"Independent Director"},{"name":"Venkita Subramanian Rajan","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"524500","nseId":"KILITCH","series":"EQ","isinid":"INE729D01010"}}}

          • Registered Office

          • Registrars

          • Management

            • Mukund P Mehta

              Managing Director

            • Bhavin Mukund Mehta

              Whole Time Director

            • Mira B Mehta

              Whole Time Director

            • Hemang J Engineer

              Independent Director

            • Venkita Subramanian Rajan

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              524500

            • NSE:

              KILITCH

            • Series

              EQ

            • ISIN

              INE729D01010

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347